Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

multiple myeloma

  • Open Access
    New Developments in Myeloma Treatment and Response Assessment
    Françoise Kraeber-Bodéré, Bastien Jamet, Davide Bezzi, Elena Zamagni, Philippe Moreau and Cristina Nanni
    Journal of Nuclear Medicine September 1, 2023, 64 (9) 1331-1343; DOI: https://doi.org/10.2967/jnumed.122.264972
  • Molecular Signature of <sup>18</sup>F-FDG PET Biomarkers in Newly Diagnosed Multiple Myeloma Patients: A Genome-Wide Transcriptome Analysis from the CASSIOPET Study
    You have access
    Molecular Signature of 18F-FDG PET Biomarkers in Newly Diagnosed Multiple Myeloma Patients: A Genome-Wide Transcriptome Analysis from the CASSIOPET Study
    Jean-Baptiste Alberge, Françoise Kraeber-Bodéré, Bastien Jamet, Cyrille Touzeau, Hélène Caillon, Soraya Wuilleme, Marie-Christine Béné, Tobias Kampfenkel, Pieter Sonneveld, Mark van Duin, Herve Avet-Loiseau, Jill Corre, Florence Magrangeas, Thomas Carlier, Caroline Bodet-Milin, Michel Chérel, Philippe Moreau, Stéphane Minvielle and Clément Bailly
    Journal of Nuclear Medicine July 1, 2022, 63 (7) 1008-1013; DOI: https://doi.org/10.2967/jnumed.121.262884
  • Comparison of CD38-Targeted α- Versus β-Radionuclide Therapy of Disseminated Multiple Myeloma in an Animal Model
    You have access
    Comparison of CD38-Targeted α- Versus β-Radionuclide Therapy of Disseminated Multiple Myeloma in an Animal Model
    Megan Minnix, Vikram Adhikarla, Enrico Caserta, Erasmus Poku, Russell Rockne, John E. Shively and Flavia Pichiorri
    Journal of Nuclear Medicine June 1, 2021, 62 (6) 795-801; DOI: https://doi.org/10.2967/jnumed.120.251983
  • Open Access
    212Pb α-Radioimmunotherapy Targeting CD38 in Multiple Myeloma: A Preclinical Study
    Isabelle Quelven, Jacques Monteil, Magali Sage, Amal Saidi, Jérémy Mounier, Audrey Bayout, Julie Garrier, Michel Cogne and Stéphanie Durand-Panteix
    Journal of Nuclear Medicine July 1, 2020, 61 (7) 1058-1065; DOI: https://doi.org/10.2967/jnumed.119.239491
  • You have access
    Hexokinase-2 Expression in 11C-Methionine–Positive, 18F-FDG–Negative Multiple Myeloma
    Stefan Kircher, Antje Stolzenburg, Klaus Martin Kortüm, Malte Kircher, Matteo Da Via, Samuel Samnick, Andreas K. Buck, Hermann Einsele, Andreas Rosenwald and Constantin Lapa
    Journal of Nuclear Medicine March 1, 2019, 60 (3) 348-352; DOI: https://doi.org/10.2967/jnumed.118.217539
  • You have access
    Imaging Melphalan Therapy Response in Preclinical Extramedullary Multiple Myeloma with 18F-FDOPA and 18F-FDG PET
    Deep K. Hathi, Elizabeth N. DeLassus, Samuel Achilefu, Jonathan McConathy and Monica Shokeen
    Journal of Nuclear Medicine October 1, 2018, 59 (10) 1551-1557; DOI: https://doi.org/10.2967/jnumed.118.208744
  • You have access
    Ex Vivo and In Vivo Evaluation of Overexpressed VLA-4 in Multiple Myeloma Using LLP2A Imaging Agents
    Deepti Soodgupta, Haiying Zhou, Wissam Beaino, Lan Lu, Michael Rettig, Mark Snee, James Skeath, John F. DiPersio, Walter J. Akers, Richard Laforest, Carolyn J. Anderson, Michael H. Tomasson and Monica Shokeen
    Journal of Nuclear Medicine April 1, 2016, 57 (4) 640-645; DOI: https://doi.org/10.2967/jnumed.115.164624
  • You have access
    First-in-Human Experience of CXCR4-Directed Endoradiotherapy with 177Lu- and 90Y-Labeled Pentixather in Advanced-Stage Multiple Myeloma with Extensive Intra- and Extramedullary Disease
    Ken Herrmann, Margret Schottelius, Constantin Lapa, Theresa Osl, Andreas Poschenrieder, Heribert Hänscheid, Katharina Lückerath, Martin Schreder, Christina Bluemel, Markus Knott, Ulrich Keller, Andreas Schirbel, Samuel Samnick, Michael Lassmann, Saskia Kropf, Andreas K. Buck, Hermann Einsele, Hans-Juergen Wester and Stefan Knop
    Journal of Nuclear Medicine February 1, 2016, 57 (2) 248-251; DOI: https://doi.org/10.2967/jnumed.115.167361
  • You have access
    213Bi Radioimmunotherapy with an Anti-mCD138 Monoclonal Antibody in a Murine Model of Multiple Myeloma
    Michel Chérel, Sébastien Gouard, Joëlle Gaschet, Catherine Saï-Maurel, Frank Bruchertseifer, Alfred Morgenstern, Mickael Bourgeois, Jean-François Gestin, Françoise Kraeber Bodéré, Jacques Barbet, Philippe Moreau and François Davodeau
    Journal of Nuclear Medicine September 1, 2013, 54 (9) 1597-1604; DOI: https://doi.org/10.2967/jnumed.112.111997
  • You have access
    Metabolic Tumor Volume Assessed by 18F-FDG PET/CT for the Prediction of Outcome in Patients with Multiple Myeloma
    Rosa Fonti, Michele Larobina, Silvana Del Vecchio, Serena De Luca, Rossella Fabbricini, Lucio Catalano, Fabrizio Pane, Marco Salvatore and Leonardo Pace
    Journal of Nuclear Medicine December 1, 2012, 53 (12) 1829-1835; DOI: https://doi.org/10.2967/jnumed.112.106500
SNMMI

© 2025 SNMMI

Powered by HighWire